MCLA-117
Showing 1 - 25 of 74
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)
Active, not recruiting
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
- MCLA-117 bispecific antibody
-
Augusta, Georgia
- +9 more
May 6, 2021
NSCLC?EGFR Sensitive Mutation Trial in Bengbu, Changsha, Shanghai (MCLA-129: 1500mg or 2000mg IV Q2W, Befotertinib: 75 mg or 100
Not yet recruiting
- Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
- MCLA-129: 1500mg or 2000mg IV Q2W
- Befotertinib: 75 mg or 100 mg Po QD
-
Bengbu, Anhui, China
- +2 more
Aug 28, 2023
Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)
Active, not recruiting
- Breast Cancer Metastatic
- MCLA-128
- +3 more
-
Los Angeles, California
- +24 more
Aug 10, 2022
Delayed Graft Function Trial (ARGX-117, Placebo)
Not yet recruiting
- Delayed Graft Function
- ARGX-117
- Placebo
- (no location specified)
Jun 8, 2023
Multifocal Motor Neuropathy Trial in Worldwide (ARGX-117, Placebo)
Recruiting
- Multifocal Motor Neuropathy
- ARGX-117
- Placebo
-
Scottsdale, Arizona
- +33 more
Dec 20, 2022
Multifocal Motor Neuropathy (MMN) Trial (ARGX-117, Placebo)
Not yet recruiting
- Multifocal Motor Neuropathy (MMN)
- ARGX-117
- Placebo
- (no location specified)
Jun 1, 2022
Acute Posthemorrhagic Anemia Trial in Gosford (drug, dietary supplement, other)
Withdrawn
- Acute Posthemorrhagic Anemia
- BGE-117, 4mg
- +3 more
-
Gosford, New South Wales, AustraliaRenal Research
Apr 29, 2022
Healthy Volunteers Trial in Groningen (ARGX-117, Placebo, ARGX-117 + rHuPH20)
Active, not recruiting
- Healthy Volunteers
- ARGX-117
- +5 more
-
Groningen, NetherlandsInvestigator Site 1
Feb 7, 2022
NSCLC Metastatic, Gastric Cancer, Head Neck Cancer Trial in Orange, West Valley City (MCLA-129)
Recruiting
- Non-Small Cell Lung Cancer Metastatic
- +2 more
-
Orange, California
- +1 more
May 21, 2021
Acute Myeloid Leukemia, Myelodysplasia Trial in United States (MGTA-117)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- MGTA-117
-
Duarte, California
- +7 more
Nov 23, 2022
Advanced Solid Tumor Trial in Sioux Falls (paclitaxel, TAK-228, TAK-117)
Active, not recruiting
- Advanced Solid Tumor
- paclitaxel
- +2 more
-
Sioux Falls, South DakotaAvera Cancer Institute
Aug 24, 2021
MDD Trial in Worldwide (MIN-117 5.0 mg, MIN-117 2.5 mg, Placebo)
Completed
- Major Depressive Disorder
- MIN-117 5.0 mg
- +2 more
-
Little Rock, Arkansas
- +46 more
Dec 14, 2020
Solid Tumor, Adult Trial in Seoul (TAS-117)
Completed
- Solid Tumor, Adult
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Apr 21, 2021
Patients Suffering From Acute Non-traumatic Subarachnoid
Recruiting
- Subarachnoid Hemorrhage
-
Debrecen, Hajdú-Bihar, HungaryDr. Szántó Dorottya
Jun 27, 2022
Rockall Scoring System in Predicting Outcomes From Variceal
Completed
- Bleeding Esophageal
- Assessment tool to determine severity of GI bleeding
- (no location specified)
Nov 20, 2023
Emergencies, Orthopedics, Radial Head Subluxation Trial in Istanbul (Supination-flexion maneuver, Hyperpronation maneuver)
Not yet recruiting
- Emergencies
- +2 more
- Supination-flexion maneuver
- Hyperpronation maneuver
-
Istanbul, TurkeyUmraniye Research and Training Hospital
Apr 12, 2023
Infertility, IVF Trial in Singapore (ICSI, PICSI)
Recruiting
- Infertility
- IVF
- ICSI
- PICSI
-
Singapore, SingaporeKK Women's and Children's Hospital
Mar 30, 2022
Changes of Bone Mineral Density in Total Hip Arthroplasty
Completed
- Bone Mineral Density
- (no location specified)
Jul 10, 2021
Safety of Exposure to Natalizumab During Pregnancy
Recruiting
- Multiple Sclerosis
- Questionnaire
-
Besançon, France
- +26 more
Jun 27, 2022
Parameters in or Without Microcornea Within Less Than One Year
Completed
- Microcornea Within One Year of Age
- Collect ocular biological parameters including age, corneal diameter, eye axis, intraocular pressure, steep&flat axis of corneal curvature, corneal thickness, lens thickness, anterior chamber depth
-
Hangzhou, Zhejiang, ChinaWenzhou Medical University
Apr 15, 2021
Primary Open-angle Glaucoma and Ocular Hypertension Trial in United States (DE-117 Ophthalmic Solution QD, DE-117 Ophthalmic
Completed
- Primary Open-angle Glaucoma and Ocular Hypertension
- DE-117 Ophthalmic Solution QD
- DE-117 Ophthalmic Solution BID
-
Los Angeles, California
- +12 more
Jul 20, 2020